STOCK TITAN

Enhabit Home Health & Hospice announces date of 2022 second quarter earnings call

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags

Rhea-AI Summary

Enhabit Home Health & Hospice (NYSE: EHAB) announced it will report its second-quarter results for the period ending June 30, 2022, after market hours on August 1, 2022. The company will hold its first investor conference call as a publicly traded entity on August 2, 2022, at 11 a.m. ET. Investors can access the call by dialing 888-660-6150 with conference ID 5248158. A live webcast and replay will be available on the company's investor website. Enhabit operates 252 home health and 99 hospice locations across 34 states, focusing on patient-centered care.

Loading...
Loading translation...

Positive

  • Hosting first earnings call as a publicly traded company.
  • Wide operational footprint with 252 home health locations and 99 hospice locations across 34 states.

Negative

  • None.
Argus Session date unavailable
-0.05% session move Open Argus
Details

News Market Reaction – EHAB

The recorded move for EHAB in the trading session of this news was -0.05%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

DALLAS, July 7, 2022 /PRNewswire/ -- Enhabit Home Health & Hospice (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the second quarter ended June 30, 2022, after the market closes on Aug. 1, 2022. The Company will host its first investor conference call as an independent, publicly traded company to discuss its results for the quarter at 11 a.m. ET on Aug. 2, 2022.

The conference call may be accessed by dialing 888-660-6150 and giving the conference ID 5248158. International callers may dial 929-203-0843 and give the same conference ID. Please dial in approximately 10 minutes before the start of the call to ensure you are connected.

A live webcast of the conference call and an online replay of the conference call can be found on the Company's investor website at https://investors.ehab.com. 

About Enhabit Home Health & Hospice  

Enhabit Home Health & Hospice is a leading national home health and hospice provider working to expand what's possible for patient care in the home. The company's team of clinicians supports patients and their families where they are most comfortable, with a nationwide footprint spanning 252 home health locations and 99 hospice locations across 34 states. Enhabit leverages advanced technology and compassionate teams to deliver extraordinary patient care. For more information, visit ehab.com.  

Media contact
Erin Volbeda
media@ehab.com
972-338-5141

Investor relations contact
Jennifer Hills
jennifer.hills@ehab.com
469-621-6496

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/enhabit-home-health--hospice-announces-date-of-2022-second-quarter-earnings-call-301581857.html

SOURCE Enhabit Home Health & Hospice

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Enhabit report its second-quarter earnings?

Enhabit will report its second-quarter earnings on August 1, 2022, after market close.

What time is the investor conference call for Enhabit?

The investor conference call will take place on August 2, 2022, at 11 a.m. ET.

How can I access the conference call for Enhabit?

You can access the conference call by dialing 888-660-6150 and using conference ID 5248158.

Where can I find the webcast for Enhabit's earnings call?

The webcast for Enhabit's earnings call can be found on their investor website.

Keep reading